Search

Voyager Therapeutics Inc

Slēgts

3.45 -4.96

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.44

Max

3.49

Galvenie mērījumi

By Trading Economics

Ienākumi

-511K

-28M

Pārdošana

-13M

2.6M

EPS

-0.47

Peļņas marža

-1,077.401

Darbinieki

141

EBITDA

1.9M

-27M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+394.19% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-16M

219M

Iepriekšējā atvēršanas cena

8.41

Iepriekšējā slēgšanas cena

3.45

Voyager Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 11. jūl. 23:51 UTC

Cryptocurrency declines amid cautious investor sentiment ahead of key inflation data and geopolitical tensions impacting U.S. markets.

2026. g. 11. jūl. 23:51 UTC

Cryptocurrency prices dip amid geopolitical tensions and cautious investor sentiment ahead of key U.S. inflation reports.

2026. g. 11. jūl. 23:51 UTC

U.S. Stocks Rise Amid AI Enthusiasm and Geopolitical Tensions; Key Inflation Data and China's Declining Retail Sales Loom Ahead.

2026. g. 11. jūl. 23:51 UTC

Cryptocurrency market dips as Bitcoin and Ethereum decline, while U.S. stocks rise ahead of key inflation data and China's retail sales forecast shows potential consumer spending weakness.

2026. g. 11. jūl. 23:51 UTC

Mixed sentiment ahead of NAB Business Confidence report release on July 14, amid ongoing economic concerns and geopolitical uncertainties in Australia.

2026. g. 11. jūl. 23:51 UTC

Correlated Moves

Bitcoin is lower during Saturday's session, continuing a decline since Friday's close. Volatility included a session high earlier before pulling back.

2026. g. 11. jūl. 23:41 UTC

U.S. Retail Sales Ex Autos Expected to Decline 0.1% in June Amid Weakening Consumer Spending and Economic Uncertainty

2026. g. 11. jūl. 23:41 UTC

Philadelphia Fed Manufacturing Index Release on July 16, 2026, Amid Cautious Market Sentiment Due to Geopolitical Tensions and Upcoming Economic Data.

2026. g. 11. jūl. 23:41 UTC

U.S. Retail Sales Expected to Rise 0.3% in June Amid Strong Consumer Spending Trends, According to Bank of America Report

2026. g. 11. jūl. 23:31 UTC

Canada's Housing Starts Data for June 2026 Expected at 260K Amid Economic Volatility and Affordability Concerns.

2026. g. 11. jūl. 23:21 UTC

U.S. Core Producer Prices Expected to Rise 0.4% in June Amid Mixed Global Inflation Signals and Economic Uncertainties

2026. g. 11. jūl. 23:21 UTC

Cautious Market Sentiment Ahead of July 15 Release of NY Empire State Manufacturing Index Amid Geopolitical Tensions and Earnings Reports

2026. g. 11. jūl. 23:21 UTC

Producers Price Inflation (PPI) MoM for June 2026 set to release on July 15, with a forecasted increase of 0.2%, influencing potential Federal Reserve interest rate decisions amid ongoing inflation concerns.

2026. g. 11. jūl. 23:11 UTC

Brazil's Retail Sales Report on July 16, 2026, Expected to Show Volatility Amid Economic Uncertainty and Mixed Previous Results.

2026. g. 11. jūl. 23:01 UTC

Investors Cautiously Await U.S. Core Inflation Rate Release Amid Geopolitical Tensions and Earnings Uncertainty

2026. g. 11. jūl. 23:01 UTC

Upcoming U.S. CPI Release on July 14 Sparks Caution Among Investors Amid Inflation Concerns and Geopolitical Tensions

2026. g. 11. jūl. 23:01 UTC

Investors Brace for July 14 CPI Release Amid High Inflation Concerns and Potential Fed Rate Hike

2026. g. 11. jūl. 23:01 UTC

Investors Brace for July CPI Release Amid Inflation Concerns and Market Volatility

2026. g. 11. jūl. 23:01 UTC

US Core Inflation Rate Expected to Rise 0.3% in June Amid Market Caution and Geopolitical Tensions

2026. g. 11. jūl. 23:01 UTC

U.S. Inflation Rate Expected to Decrease Slightly in June Amid Cautious Market Sentiment and Geopolitical Tensions

2026. g. 11. jūl. 23:01 UTC

Correlated Moves

The Dow Jones Index declined during after-market hours, reflecting cumulative weakness since Friday's close amid broader market sentiment.

2026. g. 11. jūl. 22:53 UTC

Australia's Westpac Consumer Confidence Index set for July 14, 2026 release amid optimistic market sentiment following positive employment figures and easing geopolitical tensions.

2026. g. 11. jūl. 22:53 UTC

Australia's Westpac Consumer Confidence report on July 14, 2026, is expected to show improvement amid positive stock market gains and ongoing inflation concerns.

2026. g. 11. jūl. 22:41 UTC

MBA 30-Year Mortgage Rate Release on July 15 Expected to Reflect Ongoing Inflation and Geopolitical Tensions Impacting Market Sentiment.

2026. g. 11. jūl. 22:31 UTC

Brazil's Central Bank to Provide Key Interest Rate Outlook on July 13, Amid Global Inflationary Trends.

2026. g. 11. jūl. 22:31 UTC

Japan's Machinery Orders Expected to Decline by 4.2% in May Amid Mixed Economic Sentiment and Geopolitical Tensions

2026. g. 11. jūl. 22:21 UTC

Singapore's Upcoming GDP Growth Rate Release Sparks Cautious Optimism Amid Regional Market Trends and Global Economic Factors

2026. g. 11. jūl. 21:41 UTC

South Korea's Unemployment Rate Release on July 14 Expected to Show Increase Amid Economic Concerns and Job Losses.

2026. g. 11. jūl. 21:31 UTC

UK Retail Sales Monitor YoY Forecasts 2.9% Growth Amid Mixed Sentiment and Geopolitical Concerns Ahead of July Release

2026. g. 11. jūl. 20:41 UTC

India's June 2026 Inflation Rate Expected at 4.3%, Amid Rising Prices and Geopolitical Concerns

Salīdzinājums

Cenas izmaiņa

Voyager Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

394.19% augšup

Prognoze 12 mēnešiem

Vidējais 17 USD  394.19%

Augstākais 25 USD

Zemākais 8 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Voyager Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

6

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
help-icon Live chat